Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 1,651,367 $ 381,566 $ 3,085,918 $ 5,037,429
General and administrative 1,126,530 817,898 3,244,856 4,608,755
Total operating expenses 2,777,897 1,199,464 6,330,774 9,646,184
Loss from operations (2,777,897) (1,199,464) (6,330,774) (9,646,184)
Other income (expense):        
Change in fair value of warrant liability 92,561   8,260,735 0
Other income (expense) 56,960 28,728 152,688 24,221
Total other income (expense), net 149,521 28,728 8,413,423 24,221
Net (loss) income $ (2,628,376) $ (1,170,736) $ 2,082,649 $ (9,621,963)
Net (loss) earnings per share, basic $ (0.42) $ (1.91) $ 0.43 $ (19.61)
Weighted-average shares used to compute net (loss) earnings per share, basic 6,297,303 611,998 4,857,628 490,562
Net (loss) earnings per share, diluted $ (0.42) $ (1.91) $ 0.41 $ (19.61)
Weighted-average shares used to compute net (loss) earnings per share, diluted 6,297,303 611,998 5,024,091 490,562